文献速递免疫规划传染病防控与疫情报告

鼻内递送由卷曲菌毛纤维与高度保守M2e表位组成的自佐剂纳米疫苗可保护小鼠抵抗甲型流感病毒

Intranasal delivery of a self-adjuvanted nanovaccine composed of the curli filaments and the highly conserved M2e epitope confers protection against influenza a virus in mice.
PubMed 文献 · Vaccine · 2024-03-08

该研究基于CsgA蛋白片段R4R5构建的纳米颗粒,偶联三个拷贝的高度保守M2e表位(3M2e-R4R5),经鼻内滴注免疫小鼠,无需额外佐剂即可诱导系统和呼吸道局部M2e特异性体液与细胞免疫并激活肺泡巨噬细胞,保护小鼠抵抗致死性甲型流感病毒攻击。

要点

  • 鼻内接种3M2e-R4R5纳米疫苗无需额外佐剂即可诱导M2e特异性免疫应答。
  • 该疫苗可激发系统和呼吸道局部的体液与细胞免疫,并激活肺泡巨噬细胞。
  • 鼻内免疫保护小鼠抵抗致死性甲型流感病毒攻击。

核心结论

  • 基于CsgA的纳米结构可作为安全的自佐剂抗原递送系统用于黏膜免疫。
  • 鼻内接种3M2e-R4R5纳米疫苗无需额外佐剂即可保护小鼠抵抗致死性甲型流感病毒攻击。

研究设计与样本

  • 研究将三个重复的高度保守M2e表位与CsgA蛋白片段R4R5偶联构建3M2e-R4R5纳米疫苗,经鼻内滴注免疫小鼠,并评估其抵抗致死性甲型流感病毒攻击的效果。

主要发现

  • 鼻内接种3M2e-R4R5纳米疫苗触发系统和呼吸道局部强烈的M2e特异性体液与细胞应答,并激活肺泡巨噬细胞。
  • 鼻内疫苗无需额外佐剂即保护小鼠抵抗致死性甲型流感病毒攻击。

关键数值与推荐

  • 原文未报告具体的免疫原性指标数值、攻击剂量或保护率等定量标准。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Intranasal administration of vaccines is an attractive delivery route to fight viral respiratory infections. However, there are only a few intranasal vaccines used in human, emphasizing the critical need to identify novel safe mucosal adjuvants and antigen delivery systems to expand their usage. We recently revealed an immunostimulating nanoparticle based on a fragment (R4R5) of the Curli-specific gene A (CsgA) protein that confers protection against influenza A virus (IAV) when conjugated to three repeats of the highly conserved M2e epitope and administrated intramuscularly. Herein, the efficacy of this 3M2e-R4R5 nanovaccine was investigated upon administration by intranasal instillation. By triggering robust M2e-specific humoral and cellular responses, both systemic and locally in the respiratory tract, and by priming alveolar macrophages, the intranasal vaccine protected mice against a lethal IAV challenge without the use of additional adjuvant. Thus, CsgA-based nanostructures could serve as a safe and self-adjuvanted antigen delivery system for mucosal immunization.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. St-Louis P, Martin C, Khatri V, et al. Intranasal delivery of a self-adjuvanted nanovaccine composed of the curli filaments and the highly conserved M2e epitope confers protection against influenza a virus in mice. Vaccine. 2024. PMID: 38461047. doi:10.1016/j.vaccine.2024.02.063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。